COMPARATIVE ANALYSIS OF PATHOGENICITY OF INFLUENZA A(H5N1) AND A(H1N1)pdm09 VIRUSES IN MICE

Cover Page


Cite item

Full Text

Abstract

Aim. Compare the degree of pathogenicity of newly emerging influenza virus strains with pandemic potential by experimental infection of BALB/c mice with highly pathogenic avian influenza A(H5N1) virus and mouse adapted pandemic influenza A(H1N1)pdm09 virus. Materials and methods. The first group of BALB/c mice (n=24) were infected with highly pathogenic avian influenza A(H5N1) virus in a dose of 5 LD50, and the second group (n=24) were infected with mouse adapted pandemic influenza A(H1N1)pdm09 virus at a dose of 5 LD50. Determination of LD50 and TCID50 were performed by virological methods. Morphological changes in internal organs (lung, brain, liver, kidney, spleen) were examined by light and transmission electron microscopy. Results. Virologic analysis showed that both strains are highly lethal for mice. Microscopic examination revealed the development of interstitial pneumonia in the lungs and generalization of infection in the internal organs. Conclusion. In both groups of BALB/c mice experimentally infected with highly pathogenic avian influenza A(H5N1) and mouse adapted pandemic influenza A(H1N1)pdm09 virus were revealed the development of a highly lethal disease in the form of respiratory pneumonia. It is noted, different mechanisms of pathological process: in case of infection with mouse adapted pandemic influenza A(H1N1)pdm09 virus firstly developed bronchitis, which quickly exacerbated by the development of alveolitis, while in case of infection with highly pathogenic avian influenza A(H5N1) immediately developed alveolitis. On the 6th day after infection recorded the development of generalized infection in mice of both experimental groups.

About the authors

E. A. Prokopeva

Research Institute of Experimental and Clinical Medicine; National Research State University

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

K. A. Sharshov

Research Institute of Experimental and Clinical Medicine

Email: noemail@neicon.ru
Russian Federation

A. A. Romanovskaya

University of Helsinki

Email: noemail@neicon.ru
Russian Federation

I. A. Sobolev

Research Institute of Experimental and Clinical Medicine

Email: noemail@neicon.ru
Russian Federation

O. G. Kurskaya

Research Institute of Experimental and Clinical Medicine

Email: noemail@neicon.ru
Russian Federation

E. I. Soloveva

Research Institute of Experimental and Clinical Medicine; National Research State University

Email: noemail@neicon.ru
Russian Federation

L. V. Shestopalova

National Research State University

Email: noemail@neicon.ru
Russian Federation

A. V. Zaykovskaya

State Scientific Centre of Virology and Biotechnology «Vector»

Email: noemail@neicon.ru
Russian Federation

A. Yu. Alekseev

Research Institute of Experimental and Clinical Medicine

Email: noemail@neicon.ru
Russian Federation

A. M. Shestopalov

Research Institute of Experimental and Clinical Medicine

Email: noemail@neicon.ru
Russian Federation

References

  1. Ковнер А.В., Потапова О.В., Шкурупий В.А. Морфофункциональные изменения эндотелиоцитов сосудов легких при гриппе А/^Ю A/goose/Krasnoozerskoe/627/05 у мышей. Бюллетень экспериментальной биологии и медицины. 2012, 154 (10): 472475.
  2. Романовская А.А., Шаршов К.А., Зайковская А.В. Дурыманов А.Г., Шестопалов А.М. Штамм вируса гриппа А/Russia/01/2009-MA субтипа H1N1 для исследования лечебной и профилактической активности противовирусных препаратов in vitro и in vivo. Патент на изобретение. RUS 2451072 18.10.2010.
  3. Belser J.A., Szretter K.J., Katz J.M., Tumpey T.M. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Advances in virus research. 2009, 73: 55-97. doi: 10.1016/S0065-3527(09)73002-7.
  4. Connor R.G., Kawaoka Y., Webster R.G., Paulson JC.l. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology. 1994, 205(1): 17-23.
  5. Garigliany M.M., Habyarimana A., Lambrecht B. et al. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerging Infectious diseases. 2010, 16(4): 595-603. doi: 10.3201/eid1604.091061.
  6. Ilyushina N.A., Khalenkov A.M., Seiler J.P. et al. Adaptation of pandemic H1N1 influenza viruses in mice. J. Virology. 2010, 84 (17): 8607-8616. doi: 10.1128/JVI.00159-10.
  7. Ito T., Couceiro J.N., Kelm S. et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 1998, 72 (9): 7367-7373.
  8. Kuiken T., Taubenberger J. Pathology of human influenza revisited. Vaccine. 2008, 26: D59-D66.
  9. Manual on animal influenza diagnosis and surveillance. World Health Organization. 2002.
  10. Pandemic (H1N1) 2009-update 102. World Health Organization. http://www.who.int/csr/ don/2010_05_28/en/index.html (Дата обращения 25.08.2014).
  11. Prokopyeva E.A., Romanovskaya A.A., Sharshov K.A. et al. Pathogenicity assessment of A(H1N1)pdm09 and A(H5N1) viruses. Histology and Histopathology. 2017, 32: 1057-1063. doi: 10.14670/HH-11-866.
  12. Prokopyeva E.A., Sobolev I.A., Prokopyev M.V., Shestopalov A.M. Adaptation of influenza A(H1N1)pdm09 virus in experimental mouse models. Infection Genetic Evolution. 2016, 29. pii: S1567-1348(16)30022-3. doi: 10.1016/j.meegid.2016.01.022.
  13. Shinya K., Ebina M., Yamada S. et al. Avian flu: influenza virus receptors in the human airway. Nature. 2006, 440 (7083): 435-436.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Prokopeva E.A., Sharshov K.A., Romanovskaya A.A., Sobolev I.A., Kurskaya O.G., Soloveva E.I., Shestopalova L.V., Zaykovskaya A.V., Alekseev A.Y., Shestopalov A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies